Discover MabDesign

MabDesign, the French association of the industrial sector of biomedicines, aims to support, structure, federate and increase the visibility of the industrial sector of biological medicines.
carl-newton-2C6kAtCXf6U-unsplash

Access our network

Join the MabDesign network to take advantage of all the advantages and opportunities offered.
casey-horner-9vf1uj6i6Ww-unsplash

Develop your skills

Consult and register for our next training courses in order to acquire new expertise.
smartworks-coworking-Uz8THWPXwhI-unsplash

Explore our business services

The field of therapeutic antibodies and immunotherapy is growing rapidly. The French industrial ecosystem is rich in innovative companies with considerable potential. MabDesign’s mission is to support them in their development in France and abroad.
arlington-research-kN_kViDchA0-unsplash

Upcoming events

Add your title here

09
Apr.
April 9-11, 2024
Partner Event
22
Apr.
April 22-23, 2024
Partner Event
29
Apr.
April 29-30, 2024
Partner Event
16
May.
16 & 17 mai 2024
Other Events
17
May.
17 May, 2024
Mabdesign Event

Our News

OSIVAX-logo

Osivax Announces Vaccination of Last Patient in Phase 2a Clinical Trial Evaluating OVX836 Combined with QIVs

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, today announced that all participants have completed their final visit in the Phase 2a clinical trial (NCT05734040) evaluating OVX836, Osivax’ broad-spectrum influenza A vaccine candidate, in combination with Quadrivalent Influenza Vaccines (QIVs).
2020-05-11_mabsilico_logos-01

Rapid Novor and MAbSilico Partner for World’s First AI-Guided Epitope Mapping Service for Antibodies

Rapid Novor Inc and MAbSilico announced that they have partnered to provide the world’s first AI-driven HDX-MS epitope mapping service for antibody development.
téhrapie génique et cellulaire ; CAR-T ; MTIs ; médicaments thérapie innovante

Advanced therapy medicinal products: from the lab to the patient's bed

Advanced therapy medicinal products (ATMPs) explore new therapeutic approaches based on genome modification, manipulation of patient or healthy donor cells and other innovative methods, representing a major transition from traditional medicine to more personalized and targeted medicine.
TTT logo

Toulouse Tech Transfer (TTT) - new member

Toulouse Tech Transfer (TTT) est la Société d’Accélération du Transfert de Technologies (SATT) d’Occitanie ouest, créée en 2012 dans le cadre du Programme des Investissements d’Avenir.

OUR BOARD OF DIRECTORS